Importance of resectability status in neoadjuvant treatment for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.
Sho M, et al. Among authors: hasegawa m.
J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):563-70. doi: 10.1002/jhbp.258. Epub 2015 Apr 29.
J Hepatobiliary Pancreat Sci. 2015.
PMID: 25921623